Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs

Platinum(II) complexes such as cisplatin, carboplatin and oxaliplatin are clinically approved for the therapy of various solid tumors. Challenging pathogenic properties of cancer cells and the response of cancers towards platinum-based drugs are strongly influenced by non-coding small RNA molecules,...

Descripción completa

Detalles Bibliográficos
Autor principal: Biersack, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096430/
https://www.ncbi.nlm.nih.gov/pubmed/30159416
http://dx.doi.org/10.1016/j.ncrna.2016.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096430/
https://www.ncbi.nlm.nih.gov/pubmed/30159416
http://dx.doi.org/10.1016/j.ncrna.2016.10.001

Ejemplares similares